Tim McCarthy | LifeSci Advisors |
Sergio Traversa | Chief Executive Officer |
Cedric O'Gorman | Chief Medical Officer |
Maged Shenouda | Maged Shenouda |
Rudy Li | SVB Securities |
Uy Ear | Mizuho |
Andrew Tsai | Jefferies |
Andrea Tan | Goldman Sachs |
Yatin Suneja | Guggenheim Partners |
Good afternoon. Thank you for attending today's Relmada Therapeutics Inc.
First Quarter 2023 Earnings Call. My name is Forum [ph], and I will be your moderator for today's call. All lines will remain muted during the presentation portion of the call with an opportunity for questions-and-answers at the end.